HEADER OXIDOREDUCTASE 26-JAN-07 2OP1 TITLE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ENOYL ACP REDUCTASE WITH TITLE 2 TRICLOSAN REDUCTASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 GENE: FABI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODON+-RIL CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS PFENR, MALARIA, TRICLOSAN ANALOG, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR H.TSAI REVDAT 4 13-JUL-11 2OP1 1 VERSN REVDAT 3 24-FEB-09 2OP1 1 VERSN REVDAT 2 09-OCT-07 2OP1 1 JRNL REVDAT 1 17-JUL-07 2OP1 0 JRNL AUTH J.S.FREUNDLICH,F.WANG,H.-C.TSAI,M.KUO,H.-M.SHIEH, JRNL AUTH 2 J.W.ANDERSON,L.J.NKRUMAH,J.-C.VALDERRAMOS,M.YU,T.R.S.KUMAR, JRNL AUTH 3 S.G.VALDERRAMOS,W.R.JACOBS,G.A.SCHIEHSER,D.P.JACOBUS, JRNL AUTH 4 D.A.FIDOCK,J.C.SACCHETTINI JRNL TITL X-RAY STRUCTURAL ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL JRNL TITL 2 ACYL CARRIER PROTEIN REDUCTASE AS A PATHWAY TOWARD THE JRNL TITL 3 OPTIMIZATION OF TRICLOSAN ANTIMALARIAL EFFICACY JRNL REF J.BIOL.CHEM. V. 282 25436 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17567585 JRNL DOI 10.1074/JBC.M701813200 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX AND REFMAC REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 21372 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1148 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4399 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 134 REMARK 3 SOLVENT ATOMS : 123 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OP1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-APR-07. REMARK 100 THE RCSB ID CODE IS RCSB041409. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22516 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: XFIT REMARK 200 STARTING MODEL: 1NHD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.35M (NH4)2SO4, 0.1M ACONA, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.16700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 65.74900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 65.74900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 61.75050 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 65.74900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 65.74900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.58350 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 65.74900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.74900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 61.75050 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 65.74900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.74900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.58350 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.16700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 24440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 37170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -192.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 131.49800 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 131.49800 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.16700 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 88 REMARK 465 VAL A 89 REMARK 465 HIS A 90 REMARK 465 HIS A 91 REMARK 465 HIS A 92 REMARK 465 HIS A 93 REMARK 465 HIS A 94 REMARK 465 HIS A 95 REMARK 465 ASN A 96 REMARK 465 ASP A 154 REMARK 465 LYS A 155 REMARK 465 ARG A 318 REMARK 465 ALA A 319 REMARK 465 ALA A 320 REMARK 465 THR A 321 REMARK 465 ALA A 322 REMARK 465 ILE A 323 REMARK 465 ASN A 324 REMARK 465 LYS A 325 REMARK 465 LEU A 326 REMARK 465 ASN A 327 REMARK 465 ASN A 328 REMARK 465 THR A 329 REMARK 465 TYR A 330 REMARK 465 GLU A 331 REMARK 465 ASN A 332 REMARK 465 ASN A 333 REMARK 465 THR A 334 REMARK 465 ASN A 335 REMARK 465 GLN A 336 REMARK 465 ASN A 337 REMARK 465 LYS A 338 REMARK 465 ASN A 339 REMARK 465 ARG A 340 REMARK 465 ASN A 341 REMARK 465 SER A 342 REMARK 465 HIS A 343 REMARK 465 ASP A 344 REMARK 465 VAL A 345 REMARK 465 HIS A 346 REMARK 465 ASN A 347 REMARK 465 ILE A 348 REMARK 465 MET A 349 REMARK 465 ASN A 350 REMARK 465 ASN A 351 REMARK 465 SER A 352 REMARK 465 GLY A 353 REMARK 465 GLU A 354 REMARK 465 LYS A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 LYS A 358 REMARK 465 LYS A 359 REMARK 465 ASN A 360 REMARK 465 SER A 361 REMARK 465 ALA A 362 REMARK 465 SER A 363 REMARK 465 GLN A 364 REMARK 465 ASN A 365 REMARK 465 TYR A 366 REMARK 465 ASP A 425 REMARK 465 MET B 88 REMARK 465 VAL B 89 REMARK 465 HIS B 90 REMARK 465 HIS B 91 REMARK 465 HIS B 92 REMARK 465 HIS B 93 REMARK 465 HIS B 94 REMARK 465 HIS B 95 REMARK 465 ASN B 96 REMARK 465 GLU B 97 REMARK 465 ILE B 153 REMARK 465 ASP B 154 REMARK 465 LYS B 155 REMARK 465 ASP B 156 REMARK 465 LYS B 157 REMARK 465 LYS B 325 REMARK 465 LEU B 326 REMARK 465 ASN B 327 REMARK 465 ASN B 328 REMARK 465 THR B 329 REMARK 465 TYR B 330 REMARK 465 GLU B 331 REMARK 465 ASN B 332 REMARK 465 ASN B 333 REMARK 465 THR B 334 REMARK 465 ASN B 335 REMARK 465 GLN B 336 REMARK 465 ASN B 337 REMARK 465 LYS B 338 REMARK 465 ASN B 339 REMARK 465 ARG B 340 REMARK 465 ASN B 341 REMARK 465 SER B 342 REMARK 465 HIS B 343 REMARK 465 ASP B 344 REMARK 465 VAL B 345 REMARK 465 HIS B 346 REMARK 465 ASN B 347 REMARK 465 ILE B 348 REMARK 465 MET B 349 REMARK 465 ASN B 350 REMARK 465 ASN B 351 REMARK 465 SER B 352 REMARK 465 GLY B 353 REMARK 465 GLU B 354 REMARK 465 LYS B 355 REMARK 465 GLU B 356 REMARK 465 GLU B 357 REMARK 465 LYS B 358 REMARK 465 LYS B 359 REMARK 465 ASN B 360 REMARK 465 SER B 361 REMARK 465 ALA B 362 REMARK 465 SER B 363 REMARK 465 GLN B 364 REMARK 465 ASN B 365 REMARK 465 TYR B 366 REMARK 465 ASP B 425 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 238 CA - CB - CG ANGL. DEV. = -14.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 144 8.08 -69.94 REMARK 500 LYS A 185 -73.81 -42.41 REMARK 500 SER A 242 -60.72 -120.06 REMARK 500 ASP A 414 24.95 -156.16 REMARK 500 ASN A 415 15.38 59.42 REMARK 500 PHE A 421 -73.68 -101.80 REMARK 500 ASP B 107 -171.72 -176.94 REMARK 500 ASN B 160 74.55 -110.62 REMARK 500 ASN B 188 -71.65 -34.25 REMARK 500 MET B 189 -20.33 109.63 REMARK 500 GLN B 259 73.39 -111.68 REMARK 500 ASP B 414 30.37 -153.70 REMARK 500 ASN B 415 18.89 53.40 REMARK 500 PHE B 421 -67.28 -97.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASN B 188 22.4 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 8PC A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 8PC B 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NHD RELATED DB: PDB REMARK 900 SAME PROTEIN WITHOUT BOUND INHIBITOR REMARK 900 RELATED ID: 1NHG RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN REMARK 900 RELATED ID: 1NHW RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1NNU RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1ZW1 RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1ZSN RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG DBREF 2OP1 A 96 425 UNP Q9BH77 Q9BH77_PLAFA 96 425 DBREF 2OP1 B 96 425 UNP Q9BH77 Q9BH77_PLAFA 96 425 SEQADV 2OP1 MET A 88 UNP Q9BH77 CLONING ARTIFACT SEQADV 2OP1 VAL A 89 UNP Q9BH77 CLONING ARTIFACT SEQADV 2OP1 HIS A 90 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS A 91 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS A 92 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS A 93 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS A 94 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS A 95 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 MET B 88 UNP Q9BH77 CLONING ARTIFACT SEQADV 2OP1 VAL B 89 UNP Q9BH77 CLONING ARTIFACT SEQADV 2OP1 HIS B 90 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS B 91 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS B 92 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS B 93 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS B 94 UNP Q9BH77 EXPRESSION TAG SEQADV 2OP1 HIS B 95 UNP Q9BH77 EXPRESSION TAG SEQRES 1 A 338 MET VAL HIS HIS HIS HIS HIS HIS ASN GLU ASP ILE CYS SEQRES 2 A 338 PHE ILE ALA GLY ILE GLY ASP THR ASN GLY TYR GLY TRP SEQRES 3 A 338 GLY ILE ALA LYS GLU LEU SER LYS ARG ASN VAL LYS ILE SEQRES 4 A 338 ILE PHE GLY ILE TRP PRO PRO VAL TYR ASN ILE PHE MET SEQRES 5 A 338 LYS ASN TYR LYS ASN GLY LYS PHE ASP ASN ASP MET ILE SEQRES 6 A 338 ILE ASP LYS ASP LYS LYS MET ASN ILE LEU ASP MET LEU SEQRES 7 A 338 PRO PHE ASP ALA SER PHE ASP THR ALA ASN ASP ILE ASP SEQRES 8 A 338 GLU GLU THR LYS ASN ASN LYS ARG TYR ASN MET LEU GLN SEQRES 9 A 338 ASN TYR THR ILE GLU ASP VAL ALA ASN LEU ILE HIS GLN SEQRES 10 A 338 LYS TYR GLY LYS ILE ASN MET LEU VAL HIS SER LEU ALA SEQRES 11 A 338 ASN ALA LYS GLU VAL GLN LYS ASP LEU LEU ASN THR SER SEQRES 12 A 338 ARG LYS GLY TYR LEU ASP ALA LEU SER LYS SER SER TYR SEQRES 13 A 338 SER LEU ILE SER LEU CYS LYS TYR PHE VAL ASN ILE MET SEQRES 14 A 338 LYS PRO GLN SER SER ILE ILE SER LEU THR TYR HIS ALA SEQRES 15 A 338 SER GLN LYS VAL VAL PRO GLY TYR GLY GLY GLY MET SER SEQRES 16 A 338 SER ALA LYS ALA ALA LEU GLU SER ASP THR ARG VAL LEU SEQRES 17 A 338 ALA TYR HIS LEU GLY ARG ASN TYR ASN ILE ARG ILE ASN SEQRES 18 A 338 THR ILE SER ALA GLY PRO LEU LYS SER ARG ALA ALA THR SEQRES 19 A 338 ALA ILE ASN LYS LEU ASN ASN THR TYR GLU ASN ASN THR SEQRES 20 A 338 ASN GLN ASN LYS ASN ARG ASN SER HIS ASP VAL HIS ASN SEQRES 21 A 338 ILE MET ASN ASN SER GLY GLU LYS GLU GLU LYS LYS ASN SEQRES 22 A 338 SER ALA SER GLN ASN TYR THR PHE ILE ASP TYR ALA ILE SEQRES 23 A 338 GLU TYR SER GLU LYS TYR ALA PRO LEU ARG GLN LYS LEU SEQRES 24 A 338 LEU SER THR ASP ILE GLY SER VAL ALA SER PHE LEU LEU SEQRES 25 A 338 SER ARG GLU SER ARG ALA ILE THR GLY GLN THR ILE TYR SEQRES 26 A 338 VAL ASP ASN GLY LEU ASN ILE MET PHE LEU PRO ASP ASP SEQRES 1 B 338 MET VAL HIS HIS HIS HIS HIS HIS ASN GLU ASP ILE CYS SEQRES 2 B 338 PHE ILE ALA GLY ILE GLY ASP THR ASN GLY TYR GLY TRP SEQRES 3 B 338 GLY ILE ALA LYS GLU LEU SER LYS ARG ASN VAL LYS ILE SEQRES 4 B 338 ILE PHE GLY ILE TRP PRO PRO VAL TYR ASN ILE PHE MET SEQRES 5 B 338 LYS ASN TYR LYS ASN GLY LYS PHE ASP ASN ASP MET ILE SEQRES 6 B 338 ILE ASP LYS ASP LYS LYS MET ASN ILE LEU ASP MET LEU SEQRES 7 B 338 PRO PHE ASP ALA SER PHE ASP THR ALA ASN ASP ILE ASP SEQRES 8 B 338 GLU GLU THR LYS ASN ASN LYS ARG TYR ASN MET LEU GLN SEQRES 9 B 338 ASN TYR THR ILE GLU ASP VAL ALA ASN LEU ILE HIS GLN SEQRES 10 B 338 LYS TYR GLY LYS ILE ASN MET LEU VAL HIS SER LEU ALA SEQRES 11 B 338 ASN ALA LYS GLU VAL GLN LYS ASP LEU LEU ASN THR SER SEQRES 12 B 338 ARG LYS GLY TYR LEU ASP ALA LEU SER LYS SER SER TYR SEQRES 13 B 338 SER LEU ILE SER LEU CYS LYS TYR PHE VAL ASN ILE MET SEQRES 14 B 338 LYS PRO GLN SER SER ILE ILE SER LEU THR TYR HIS ALA SEQRES 15 B 338 SER GLN LYS VAL VAL PRO GLY TYR GLY GLY GLY MET SER SEQRES 16 B 338 SER ALA LYS ALA ALA LEU GLU SER ASP THR ARG VAL LEU SEQRES 17 B 338 ALA TYR HIS LEU GLY ARG ASN TYR ASN ILE ARG ILE ASN SEQRES 18 B 338 THR ILE SER ALA GLY PRO LEU LYS SER ARG ALA ALA THR SEQRES 19 B 338 ALA ILE ASN LYS LEU ASN ASN THR TYR GLU ASN ASN THR SEQRES 20 B 338 ASN GLN ASN LYS ASN ARG ASN SER HIS ASP VAL HIS ASN SEQRES 21 B 338 ILE MET ASN ASN SER GLY GLU LYS GLU GLU LYS LYS ASN SEQRES 22 B 338 SER ALA SER GLN ASN TYR THR PHE ILE ASP TYR ALA ILE SEQRES 23 B 338 GLU TYR SER GLU LYS TYR ALA PRO LEU ARG GLN LYS LEU SEQRES 24 B 338 LEU SER THR ASP ILE GLY SER VAL ALA SER PHE LEU LEU SEQRES 25 B 338 SER ARG GLU SER ARG ALA ILE THR GLY GLN THR ILE TYR SEQRES 26 B 338 VAL ASP ASN GLY LEU ASN ILE MET PHE LEU PRO ASP ASP HET NAD A 450 44 HET 8PC A 500 23 HET NAD B 450 44 HET 8PC B 500 23 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 8PC 2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 8PC 2(C18 H13 CL2 N O2) FORMUL 7 HOH *123(H2 O) HELIX 1 1 GLY A 110 ARG A 122 1 13 HELIX 2 2 VAL A 134 ASN A 144 1 11 HELIX 3 3 PHE A 147 ILE A 152 1 6 HELIX 4 4 THR A 173 ILE A 177 5 5 HELIX 5 5 ASP A 178 ASN A 184 1 7 HELIX 6 6 ASN A 184 MET A 189 1 6 HELIX 7 7 THR A 194 GLY A 207 1 14 HELIX 8 8 ASP A 225 THR A 229 5 5 HELIX 9 9 SER A 230 SER A 242 1 13 HELIX 10 10 SER A 242 VAL A 253 1 12 HELIX 11 11 TYR A 267 GLN A 271 5 5 HELIX 12 12 GLY A 280 ASN A 304 1 25 HELIX 13 13 THR A 367 ALA A 380 1 14 HELIX 14 14 LEU A 387 SER A 400 1 14 HELIX 15 15 ARG A 401 ARG A 404 5 4 HELIX 16 16 GLY A 416 MET A 420 5 5 HELIX 17 17 GLY B 110 ARG B 122 1 13 HELIX 18 18 TRP B 131 ASN B 144 1 14 HELIX 19 19 GLY B 145 ASN B 149 5 5 HELIX 20 20 THR B 173 ILE B 177 5 5 HELIX 21 21 ASP B 178 ASN B 184 1 7 HELIX 22 22 THR B 194 GLY B 207 1 14 HELIX 23 23 ASP B 225 THR B 229 5 5 HELIX 24 24 SER B 230 SER B 242 1 13 HELIX 25 25 SER B 242 VAL B 253 1 12 HELIX 26 26 TYR B 267 GLN B 271 5 5 HELIX 27 27 GLY B 280 ASN B 304 1 25 HELIX 28 28 SER B 317 ILE B 323 1 7 HELIX 29 29 THR B 367 ALA B 380 1 14 HELIX 30 30 LEU B 387 SER B 400 1 14 HELIX 31 31 ARG B 401 ARG B 404 5 4 HELIX 32 32 GLY B 416 MET B 420 5 5 SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N PHE A 128 O LEU A 165 SHEET 3 A 7 ILE A 99 ILE A 105 1 N ILE A 102 O ILE A 127 SHEET 4 A 7 ILE A 209 HIS A 214 1 O VAL A 213 N PHE A 101 SHEET 5 A 7 MET A 256 THR A 266 1 O ILE A 263 N HIS A 214 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N THR A 266 SHEET 7 A 7 THR A 410 VAL A 413 1 O ILE A 411 N THR A 309 SHEET 1 B 7 ILE B 161 PRO B 166 0 SHEET 2 B 7 LYS B 125 ILE B 130 1 N ILE B 130 O LEU B 165 SHEET 3 B 7 ILE B 99 ALA B 103 1 N CYS B 100 O LYS B 125 SHEET 4 B 7 ILE B 209 HIS B 214 1 O VAL B 213 N ALA B 103 SHEET 5 B 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 B 7 ARG B 306 ALA B 312 1 O ILE B 310 N THR B 266 SHEET 7 B 7 THR B 410 VAL B 413 1 O ILE B 411 N THR B 309 CISPEP 1 ASN B 188 MET B 189 0 0.90 CISPEP 2 PRO B 258 GLN B 259 0 1.56 SITE 1 AC1 23 ILE A 105 GLY A 106 GLY A 110 TYR A 111 SITE 2 AC1 23 TRP A 131 PHE A 167 ASP A 168 ALA A 169 SITE 3 AC1 23 SER A 215 LEU A 216 ALA A 217 ASN A 218 SITE 4 AC1 23 LEU A 265 THR A 266 TYR A 267 LYS A 285 SITE 5 AC1 23 ALA A 312 GLY A 313 PRO A 314 LEU A 315 SITE 6 AC1 23 SER A 317 8PC A 500 HOH A 623 SITE 1 AC2 10 ALA A 217 ASN A 218 ALA A 219 VAL A 222 SITE 2 AC2 10 TYR A 267 TYR A 277 PHE A 368 ILE A 369 SITE 3 AC2 10 ALA A 372 NAD A 450 SITE 1 AC3 29 GLY B 104 ILE B 105 GLY B 106 GLY B 110 SITE 2 AC3 29 TYR B 111 TRP B 131 PHE B 167 ASP B 168 SITE 3 AC3 29 ALA B 169 SER B 170 SER B 215 LEU B 216 SITE 4 AC3 29 ALA B 217 ASN B 218 LEU B 265 THR B 266 SITE 5 AC3 29 TYR B 267 LYS B 285 ALA B 312 GLY B 313 SITE 6 AC3 29 PRO B 314 LEU B 315 SER B 317 ARG B 318 SITE 7 AC3 29 ALA B 319 8PC B 500 HOH B 514 HOH B 642 SITE 8 AC3 29 HOH B 643 SITE 1 AC4 8 ALA B 219 TYR B 267 TYR B 277 MET B 281 SITE 2 AC4 8 LYS B 285 ALA B 319 ILE B 323 NAD B 450 CRYST1 131.498 131.498 82.334 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007605 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007605 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012146 0.00000 MASTER 435 0 4 32 14 0 19 6 0 0 0 52 END